CMV-CASANOVA Citations (2)
Originally described in: Engineered anti-CRISPR proteins for optogenetic control of CRISPR-Cas9.Bubeck F, Hoffmann MD, Harteveld Z, Aschenbrenner S, Bietz A, Waldhauer MC, Borner K, Fakhiri J, Schmelas C, Dietz L, Grimm D, Correia BE, Eils R, Niopek D Nat Methods. 2018 Oct 30. pii: 10.1038/s41592-018-0178-9. doi: 10.1038/s41592-018-0178-9. PubMed Journal
Articles Citing CMV-CASANOVA
| Articles |
|---|
Optogenetic control of Neisseria meningitidis Cas9 genome editing using an engineered, light-switchable anti-CRISPR protein.
Hoffmann MD, Mathony J, Upmeier Zu Belzen J, Harteveld Z, Aschenbrenner S, Stengl C, Grimm D, Correia BE, Eils R, Niopek D.
Nucleic Acids Res. 2021 Mar 18;49(5):e29. doi: 10.1093/nar/gkaa1198.
PubMed
Associated Plasmids |
| Photoactivatable base editors for spatiotemporally controlled genome editing in vivo. Zou Q, Lu Y, Qing B, Li N, Zhou T, Pan J, Zhang X, Zhang X, Chen Y, Sun SK. Biomaterials. 2023 Nov;302:122328. doi: 10.1016/j.biomaterials.2023.122328. Epub 2023 Sep 13. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.